Edwards Lifesciences Corporation Income Taxes Paid
Edwards Lifesciences Corporation (EW) reported Income Taxes Paid of $105.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-08-04
- Edwards Lifesciences Corporation income taxes paid for the quarter ending 2026-06-30 was $77.50M, a 77.25% decline year-over-year.
- Edwards Lifesciences Corporation income taxes paid for the quarter ending 2026-03-31 was $27.90M, a 20.51% decline year-over-year.
- Edwards Lifesciences Corporation income taxes paid for the quarter ending 2025-12-31 was $32.40M, a 94.24% decline year-over-year.
- Edwards Lifesciences Corporation income taxes paid for the quarter ending 2025-09-30 was $82.30M, a 21.54% decline year-over-year.
- Edwards Lifesciences Corporation income taxes paid for fiscal 2025 was $490.40M, a 59.00% decline from fiscal 2024.
- Edwards Lifesciences Corporation income taxes paid for fiscal 2024 was $1.20B, a 154.44% increase from fiscal 2023.
- Edwards Lifesciences Corporation income taxes paid for fiscal 2023 was $470.10M, a 6.74% decline from fiscal 2022.
- Edwards Lifesciences Corporation income taxes paid for fiscal 2022 was $504.10M, a 176.22% increase from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $77.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $105.40M 10-Q · filed 2026-08-04 | $137.80M derived: sum of 3 quarters · filed 2026-08-04 | $220.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $27.90M 10-Q · filed 2026-05-06 | $60.30M derived: sum of 2 quarters · filed 2026-05-06 | $142.60M derived: sum of 3 quarters · filed 2026-05-06 | $483.20M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $32.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $114.70M derived: sum of 2 quarters · filed 2026-02-25 | $455.30M derived: sum of 3 quarters · filed 2026-08-04 | $490.40M 10-K · filed 2026-02-25 |
| 2025-09-30 | $82.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $422.90M derived: sum of 2 quarters · filed 2026-08-04 | $458.00M 10-Q · filed 2025-11-05 | $1.02B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $340.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $375.70M 10-Q · filed 2026-08-04 | $938.00M derived: sum of 3 quarters · filed 2026-08-04 | $1.04B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $35.10M 10-Q · filed 2026-05-06 | $597.40M derived: sum of 2 quarters · filed 2026-05-06 | $702.30M derived: sum of 3 quarters · filed 2026-05-06 | $882.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $562.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $667.20M derived: sum of 2 quarters · filed 2026-02-25 | $846.90M derived: sum of 3 quarters · filed 2026-02-25 | $1.20B 10-K · filed 2026-02-25 |
| 2024-09-30 | $104.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $284.60M derived: sum of 2 quarters · filed 2025-11-05 | $633.80M 10-Q · filed 2025-11-05 | $884.80M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $179.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $528.90M 10-Q · filed 2025-08-06 | $779.90M derived: sum of 3 quarters · filed 2026-02-25 | $805.50M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $349.20M 10-Q · filed 2025-05-06 | $600.20M derived: sum of 2 quarters · filed 2026-02-25 | $625.80M derived: sum of 3 quarters · filed 2026-02-25 | $797.60M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $251.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $276.60M derived: sum of 2 quarters · filed 2026-02-25 | $448.40M derived: sum of 3 quarters · filed 2026-02-25 | $470.10M 10-K · filed 2026-02-25 |
| 2023-09-30 | $25.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $197.40M derived: sum of 2 quarters · filed 2024-11-06 | $219.10M 10-Q · filed 2024-11-06 | $407.30M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $171.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $193.50M 10-Q · filed 2024-07-31 | $381.70M derived: sum of 3 quarters · filed 2025-02-28 | $524.60M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $21.70M 10-Q · filed 2024-04-29 | $209.90M derived: sum of 2 quarters · filed 2025-02-28 | $352.80M derived: sum of 3 quarters · filed 2025-02-28 | |
| 2022-12-31 | $188.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $331.10M derived: sum of 2 quarters · filed 2025-02-28 | $504.10M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $142.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $315.90M 10-Q · filed 2023-10-27 | ||
| 2022-06-30 | $173.00M 10-Q · filed 2023-07-28 | |||
| 2021-12-31 | $69.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $115.90M derived: sum of 2 quarters · filed 2024-02-12 | $182.50M 10-K · filed 2024-02-12 | |
| 2021-09-30 | $46.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $112.60M 10-Q · filed 2022-10-28 | ||
| 2021-06-30 | $66.60M 10-Q · filed 2022-07-29 | |||
| 2020-12-31 | $197.90M 10-K · filed 2023-02-13 | |||
| 2019-12-31 | $7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $16.30M derived: sum of 2 quarters · filed 2022-02-14 | $61.50M 10-K · filed 2022-02-14 | |
| 2019-09-30 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $53.90M 10-Q · filed 2019-10-25 | ||
| 2019-06-30 | $45.20M 10-Q · filed 2019-07-26 | |||
| 2018-12-31 | -$3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $28.60M derived: sum of 2 quarters · filed 2021-02-12 | $28.60M derived: sum of 3 quarters · filed 2021-02-12 | $223.70M 10-K · filed 2021-02-12 |
| 2018-09-30 | $32.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $32.20M derived: sum of 2 quarters · filed 2019-10-25 | $227.30M 10-Q · filed 2019-10-25 | $248.60M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $195.10M 10-Q · filed 2018-07-27 | $216.40M derived: sum of 3 quarters · filed 2020-02-14 | $251.40M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $195.10M 10-Q · filed 2019-07-26 | $216.40M derived: sum of 2 quarters · filed 2020-02-14 | $251.40M derived: sum of 3 quarters · filed 2020-02-14 | |
| 2017-12-31 | $21.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $56.30M derived: sum of 2 quarters · filed 2020-02-14 | $143.70M 10-K · filed 2020-02-14 | |
| 2017-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $122.40M 10-Q · filed 2018-10-26 | ||
| 2017-06-30 | $87.40M 10-Q · filed 2018-07-27 | |||
| 2016-12-31 | $44.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $99.90M 10-K · filed 2019-02-15 | ||
| 2016-09-30 | $55.30M 10-Q · filed 2016-10-28 | |||
| 2015-12-31 | $49.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $86.90M 10-K · filed 2018-02-16 | ||
| 2015-09-30 | $37.20M 10-Q · filed 2016-10-28 | |||
| 2014-12-31 | $74.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $274.70M 10-K · filed 2017-02-17 | ||
| 2014-09-30 | $200.30M 10-Q · filed 2015-10-29 | |||
| 2013-12-31 | $54.00M 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |